Hepion Pharmaceuticals, Inc. (HEPA) Social Stream
HEPION PHARMACEUTICALS INC (HEPA) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering HEPION PHARMACEUTICALS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-01-26 | 1 | $6 | $6 | $6 | $5.45 | 10.09% |
| 2022-05-18 | 2 | $6 | $3.5 | $4.75 | $5.45 | -12.84% |
| 2022-09-01 | 2 | $6 | $2.5 | $4.25 | $5.45 | -22.02% |
| 2022-11-15 | 1 | $2.5 | $2.5 | $2.5 | $5.45 | -54.13% |
| 2023-01-23 | 1 | $4 | $2.5 | $3.25 | $5.45 | -40.37% |
| 2023-01-31 | 1 | $4 | $2.5 | $3.5 | $5.45 | -35.78% |
| 2023-04-11 | 2 | $4 | $2.5 | $3.5 | $5.45 | -35.78% |
| 2023-05-15 | 2 | $80 | $28 | $60.666 | $5.45 | 1013.14% |
| 2023-08-15 | 2 | $80 | $19 | $57.666 | $5.45 | 958.09% |
The Trend in the Analyst Price Target
Over the past 19 months, HEPA's average price target has gone up $51.67.
Over the past 39 weeks, HEPA's average upside potential has been 1,457.78%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-23 | 1 | 4 | 2.5 | 3.250 | 0.747 | 335.07% |
| 2023-01-31 | 1 | 4 | 2.5 | 3.500 | 0.730 | 379.45% |
| 2023-01-31 | 2 | 4 | 2.5 | 3.500 | 0.730 | 379.45% |
| 2023-04-11 | 2 | 80 | 50.0 | 70.000 | 0.743 | 9321.27% |
| 2023-05-15 | 2 | 80 | 28.0 | 60.666 | 6.700 | 805.46% |
HEPA Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 2 | 0 | 0 | 0 | 0 | 2 |
The Trend in the Broker Recommendations
HEPA's average broker recommendation rating improved by 0 over the prior 18 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for HEPA as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, HEPION PHARMACEUTICALS INC's number of analysts covering the stock is greater than 21.49% of them.
- To contextualize these metrics, consider that out of all US stocks, HEPION PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is greater than 332.95% of them.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, HEPION PHARMACEUTICALS INC's average analyst price target is greater than 267.27% of them.
- HEPA has a lower variance in analysts' estimates than -531.46% of stocks in the micro market cap category.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to HEPION PHARMACEUTICALS INC are LTRN, MDNA, and REVB.
View All Top Stocks by Price Target
Is HEPA a Buy, Hold or Sell? See the POWR Ratings now!